StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report sent to investors on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Price Performance
AEZS opened at $4.13 on Friday. Aeterna Zentaris has a fifty-two week low of $3.96 and a fifty-two week high of $12.00. The company’s 50-day moving average is $5.14 and its 200 day moving average is $6.67. The firm has a market capitalization of $7.41 million, a P/E ratio of -0.28 and a beta of 1.55.
Aeterna Zentaris Company Profile
Read More
- Five stocks we like better than Aeterna Zentaris
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- MarketBeat Week in Review – 9/16 – 9/20
- When to Sell a Stock for Profit or Loss
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.